Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same
申请人:Daewoong Pharmaceutical Co., Ltd.
公开号:US20200223821A1
公开(公告)日:2020-07-16
The present disclosure relates to a novel phenylpyridine derivative represented by Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of autoimmune diseases or cancers.
heterocyclic diazo compounds into allenic acids followed by base-promoted cyclization. Utilizing various diazo heterocycles, including α-diazo homophthalimides, 3-diazo tetramic acids, and diazo oxindoles, diverse spirocyclic scaffolds were produced. The research revealed that the allenic acid substitution pattern is decisive for the product type, enabling extraordinary target compound switching between
Phenylpyridine derivative and pharmaceutical composition comprising the same
申请人:Daewoong Pharmaceutical Co., Ltd.
公开号:US11149019B2
公开(公告)日:2021-10-19
The present disclosure relates to a novel phenylpyridine derivative represented by Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of autoimmune diseases or cancers.